A 10-year-old child with acute lymphoblastic leukemia (ALL) is admitted for chemotherapy. Which assessment finding would be the priority concern requiring immediate nursing intervention?

Fever with severe neutropenia (ANC 400/mm³) indicates febrile neutropenia, a life-threatening oncologic emergency requiring immediate intervention. Other findings are less urgent.

Priority Assessment for a Child with ALL Undergoing Chemotherapy

The correct answer is 3. Temperature of 101.8°F (38.8°C) with an absolute neutrophil count of 400/mm³. This presentation is the priority concern because it meets the clinical definition of febrile neutropenia (FN), a life-threatening oncologic emergency requiring immediate intervention.

Understanding the Rationale

In a patient undergoing chemotherapy for acute lymphoblastic leukemia (ALL), the immune system is profoundly compromised. Chemotherapy induces myelosuppression, leading to a severe reduction in neutrophils, the body's primary defense against bacterial and fungal infections. An absolute neutrophil count (ANC) of 400/mm³ indicates profound neutropenia. When a fever, defined as a single oral temperature of ≥101.3°F (38.5°C) or a sustained temperature of ≥100.4°F (38.0°C) for over an hour, occurs in this context, the risk of overwhelming sepsis is extremely high ^[1].

The primary clinical priority is the immediate initiation of empiric broad-spectrum antibiotics, as every hour of delay in treatment increases mortality risk. Research on pediatric FN management demonstrates that adapting standard operating procedures to reduce the time-to-antibiotic (TTA) is a critical quality improvement measure directly linked to improved patient prognosis ^[1]. The nurse's immediate intervention is to recognize this combination of a high fever and a critically low ANC, obtain blood cultures, and administer the prescribed intravenous antibiotic without delay, following institutional protocols.

Analysis of Other Options

- Option 1: Petechiae and bruising are common findings in leukemia and during chemotherapy due to thrombocytopenia. While they indicate a risk for bleeding and require careful monitoring and preventive measures, they do not represent the same level of immediate, life-threatening urgency as febrile neutropenia. The risk of death from an overwhelming infection in a neutropenic host is more acute than the risk of spontaneous bleeding from thrombocytopenia in a stable patient.
- Option 2: A temperature of 100.2°F (37.9°C) is a low-grade fever. While it warrants very close monitoring and a high index of suspicion in a neutropenic patient, it does not yet meet the strict clinical threshold for the emergency intervention protocol triggered by a higher fever. The standard of care dictates immediate action at the ≥38.5°C threshold, making option 3 the more urgent finding.
- Option 4: Headache and blurred vision are neurological symptoms that could indicate increased intracranial pressure from central nervous system (CNS) involvement of the leukemia or a serious complication like a cerebral hemorrhage. This is a critical finding. However, the combination of a high fever and documented severe neutropenia in option 3 represents a more statistically probable and rapidly fatal threat in the general pediatric oncology population. The risk of rapid progression to septic shock from a gram-negative bacteremia in a profoundly neutropenic patient is the highest priority to address first, as the initial management of FN is a time-sensitive, protocol-driven emergency ^[1]. The patient in option 4 has normal vital signs, which, while not ruling out a serious CNS event, makes the febrile, severely neutropenic patient the more unstable priority.

Clinical Application and Underlying Evidence

The urgency of this scenario is rooted in the pathophysiology of infection in the immunocompromised host. Without adequate neutrophils, the classic signs of infection—pus, abscess formation, and localized inflammation—are absent. Fever is often the only initial sign of a rapidly progressing systemic infection. Studies in pediatric oncology consistently reinforce that febrile neutropenia remains a leading cause of morbidity and mortality, particularly when effective antimicrobial therapy is delayed . The standard of care is not to wait for a source of infection to be identified but to act immediately upon the presentation of fever and neutropenia. While newer diagnostic tools like respiratory pathogen panels are being investigated to understand their impact on the hospital course, the foundational, non-negotiable intervention remains the rapid administration of empiric antibiotics . The nurse's role is to perform a rapid assessment, recognize the SIRS (Systemic Inflammatory Response Syndrome) criteria triggered by the fever in the context of immune compromise, and escalate care to deliver time-critical treatment.